Research & Development

Introduction Current Research Patents
    자료실
Home > Research & Development > Introduction
배경

    Introduction

    We challenge ourselves for better future.

We challenge ourselves for better future.
    Based on our patented Stable-peptide fusion technology (SP technology), our recombinant proteins and monoclonal antibody reagents are supplied in a variety of research institutions worldwide and it was the core technology that led ATGen to expand their field of expertize.

    We expanded into the diagnostic market, with the start of the influenza H1N1 antibody detection test kit (KFDA approved) and ELISA kit in 2009. In 2012, we introduced the first immunity diagnostic kit, NK Vue® Kit, to the market and are becoming a global leader in biotechnology industry as we develop strong products ready for the market.

ATGen's Core Technology

Super stable-peptide(SP) fusion technology

Designed for proteins that are susceptible to external environment or need to be stored for long-term or in room temperature ATGen's Core Technology

SP Fusion Technology is need in...

1. Proteins that are susceptible to external environment
2. Need to be stored for long-term
3. Need to be stored in room temperature
SP Fusion Technology is need in